Logo image of BN.CA

BROOKFIELD CORP (BN.CA) Stock Fundamental Analysis

TSX:BN - Toronto Stock Exchange - CA11271J1075 - Common Stock - Currency: CAD

74.87  -0.35 (-0.47%)

Fundamental Rating

3

Overall BN gets a fundamental rating of 3 out of 10. We evaluated BN against 83 industry peers in the Capital Markets industry. There are concerns on the financial health of BN while its profitability can be described as average. BN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
In the past year BN had a positive cash flow from operations.
BN had positive earnings in 4 of the past 5 years.
Of the past 5 years BN 4 years had a positive operating cash flow.
BN.CA Yearly Net Income VS EBIT VS OCF VS FCFBN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

With a Return On Assets value of 0.15%, BN is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
BN's Return On Equity of 1.59% is in line compared to the rest of the industry. BN outperforms 40.48% of its industry peers.
BN's Return On Invested Capital of 3.72% is in line compared to the rest of the industry. BN outperforms 44.05% of its industry peers.
BN had an Average Return On Invested Capital over the past 3 years of 3.59%. This is significantly below the industry average of 8.66%.
The last Return On Invested Capital (3.72%) for BN is above the 3 year average (3.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROIC 3.72%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.59%
ROIC(5y)3.39%
BN.CA Yearly ROA, ROE, ROICBN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BN has a Profit Margin of 0.81%. This is comparable to the rest of the industry: BN outperforms 41.67% of its industry peers.
In the last couple of years the Profit Margin of BN has declined.
BN has a Operating Margin (24.52%) which is in line with its industry peers.
BN's Operating Margin has improved in the last couple of years.
BN has a Gross Margin (18.62%) which is comparable to the rest of the industry.
BN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y-8.13%
GM growth 5Y-3.62%
BN.CA Yearly Profit, Operating, Gross MarginsBN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

BN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BN has been increased compared to 5 years ago.
BN has a better debt/assets ratio than last year.
BN.CA Yearly Shares OutstandingBN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN.CA Yearly Total Debt VS Total AssetsBN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

Based on the Altman-Z score of 0.47, we must say that BN is in the distress zone and has some risk of bankruptcy.
BN has a Altman-Z score of 0.47. This is comparable to the rest of the industry: BN outperforms 53.57% of its industry peers.
BN has a Debt/Equity ratio of 5.26. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BN (5.26) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Altman-Z 0.47
ROIC/WACCN/A
WACCN/A
BN.CA Yearly LT Debt VS Equity VS FCFBN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B 200B

2.3 Liquidity

BN has a Current Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.84, BN is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
BN has a Quick Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BN (0.66) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.66
BN.CA Yearly Current Assets VS Current LiabilitesBN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.02% over the past year.
BN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.12% yearly.
BN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.34%.
Measured over the past years, BN shows a small growth in Revenue. The Revenue has been growing by 4.86% on average per year.
EPS 1Y (TTM)31.02%
EPS 3Y-50.15%
EPS 5Y18.12%
EPS Q2Q%21.69%
Revenue 1Y (TTM)-10.34%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-20.77%

3.2 Future

BN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.28% yearly.
BN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.21% yearly.
EPS Next Y0.46%
EPS Next 2Y10.14%
EPS Next 3Y16.28%
EPS Next 5YN/A
Revenue Next Year24.4%
Revenue Next 2Y19.64%
Revenue Next 3Y20.21%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.CA Yearly Revenue VS EstimatesBN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN.CA Yearly EPS VS EstimatesBN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.16, BN is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of BN is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.35, BN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 13.09, the valuation of BN can be described as correct.
Based on the Price/Forward Earnings ratio, BN is valued a bit cheaper than 64.29% of the companies in the same industry.
BN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 13.16
Fwd PE 13.09
BN.CA Price Earnings VS Forward Price EarningsBN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BN is cheaper than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.01
BN.CA Per share dataBN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BN's earnings are expected to grow with 16.28% in the coming years.
PEG (NY)28.77
PEG (5Y)0.73
EPS Next 2Y10.14%
EPS Next 3Y16.28%

2

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.57%, which is pretty low.
BN's Dividend Yield is a higher than the industry average which is at 5.84.
With a Dividend Yield of 0.57, BN pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.57%

5.2 History

The dividend of BN decreases each year by -5.12%.
BN has paid a dividend for at least 10 years, which is a reliable track record.
BN has decreased its dividend recently.
Dividend Growth(5Y)-5.12%
Div Incr Years1
Div Non Decr Years1
BN.CA Yearly Dividends per shareBN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

BN pays out 87.94% of its income as dividend. This is not a sustainable payout ratio.
DP87.94%
EPS Next 2Y10.14%
EPS Next 3Y16.28%
BN.CA Yearly Income VS Free CF VS DividendBN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN.CA Dividend Payout.BN.CA Dividend Payout, showing the Payout Ratio.BN.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

TSX:BN (3/7/2025, 7:00:00 PM)

74.87

-0.35 (-0.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners56.84%
Inst Owner ChangeN/A
Ins Owners10.91%
Ins Owner ChangeN/A
Market Cap123.25B
Analysts76.67
Price Target100.43 (34.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.57%
Yearly Dividend0.56
Dividend Growth(5Y)-5.12%
DP87.94%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-14 2025-03-14 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.18%
Min EPS beat(2)-0.3%
Max EPS beat(2)68.65%
EPS beat(4)3
Avg EPS beat(4)20.85%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)6
Avg EPS beat(8)-3.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1592.59%
Min Revenue beat(2)1473.07%
Max Revenue beat(2)1712.11%
Revenue beat(4)4
Avg Revenue beat(4)798.76%
Min Revenue beat(4)0.84%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)413.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.85%
PT rev (3m)11.09%
EPS NQ rev (1m)-1.68%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)-1.53%
EPS NY rev (3m)-2.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)6.22%
Valuation
Industry RankSector Rank
PE 13.16
Fwd PE 13.09
P/S 0.94
P/FCF N/A
P/OCF 14.84
P/B 1.85
P/tB N/A
EV/EBITDA 10.01
EPS(TTM)5.69
EY7.6%
EPS(NY)5.72
Fwd EY7.64%
FCF(TTM)-12.19
FCFYN/A
OCF(TTM)5.05
OCFY6.74%
SpS79.34
BVpS40.47
TBVpS-22.44
PEG (NY)28.77
PEG (5Y)0.73
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROCE 5%
ROIC 3.72%
ROICexc 3.82%
ROICexgc 4.58%
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.59%
ROIC(5y)3.39%
ROICexc(3y)3.72%
ROICexc(5y)3.52%
ROICexgc(3y)4.6%
ROICexgc(5y)4.29%
ROCE(3y)4.82%
ROCE(5y)4.56%
ROICexcg growth 3Y-1.35%
ROICexcg growth 5Y2.42%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y-8.13%
GM growth 5Y-3.62%
F-Score7
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Debt/EBITDA 7.62
Cap/Depr 203.03%
Cap/Sales 21.72%
Interest Coverage 250
Cash Conversion 18.06%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.66
Altman-Z 0.47
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.02%
EPS 3Y-50.15%
EPS 5Y18.12%
EPS Q2Q%21.69%
EPS Next Y0.46%
EPS Next 2Y10.14%
EPS Next 3Y16.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.34%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-20.77%
Revenue Next Year24.4%
Revenue Next 2Y19.64%
Revenue Next 3Y20.21%
Revenue Next 5YN/A
EBIT growth 1Y25.89%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year302.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.97%
OCF growth 3YN/A
OCF growth 5YN/A